MAGEA3, which was expressed in all cells including tumor cells, is a Cancer Testis Antigen (CTA) and reported in almost all types of cancer and is considered a promising candidate for immunotherapy (Das et al., 2021). The gene discussed is MAGEA3; the disease is neoplasm.